Exane Derivatives’s Stryker SYK Stock Holding History

Exane Derivatives’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-102	Closed	-$27.3K	–	911
2022 Q1	$27.3K	Buy	+102	New	+$26.4K	0.01%	633
2021 Q4	–	Sell	-418	Closed	-$110K	–	963
2021 Q3	$110K	Sell	418 -131	-24%	-$35K	0.03%	511
2021 Q2	$144K	Sell	549 -219	-29%	-$56K	0.03%	491
2021 Q1	$187K	Sell	768 -484	-39%	-$116K	0.05%	310
2020 Q4	$307K	Sell	1,252 -2,123	-63%	-$481K	0.09%	242
2020 Q3	$703K	Buy	3,375 +63	+2%	+$12.2K	0.2%	107
2020 Q2	$597K	Buy	3,312 +2,934	+776%	+$541K	0.16%	115
2020 Q1	$62.9K	Sell	378 -84	-18%	-$16.4K	0.02%	338
2019 Q4	$95.5K	Hold	462	–	–	0.02%	323
2019 Q3	$99.9K	Hold	462	–	–	0.02%	320
2019 Q2	$94.9K	Hold	462	–	–	0.02%	336
2019 Q1	$91.2K	Buy	462 +211	+84%	+$38K	0.02%	305
2018 Q4	$39.3K	Buy	+251	New	+$42K	0.01%	382

Other funds holding SYK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's SYK Position: Q2 2022 in Review

Exane Derivatives sold out of Stryker (SYK) in Q2 2022, closing a stake of 102 shares — an estimated $27.3K sold.

Exane Derivatives first reported a position in SYK in Q4 2018 and held it in 13 quarters. The position peaked at $703K in Q3 2020. 1,581 funds tracked by Wall St. Rank hold SYK as of Q2 2022.

Exane Derivatives reported no remaining Stryker position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 102 Stryker shares in Q2 2022, an estimated $27.3K.
Exane Derivatives first reported a position in Stryker in Q4 2018 and held it in 13 quarters.
Exane Derivatives's Stryker position peaked at $703K in Q3 2020.
1,581 funds tracked by Wall St. Rank held Stryker as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.